UPDATE 2-Abbott to sell its eye care business to J&J for about $4.33 bln

Sept 16 (Reuters) - Abbott Laboratories said it

would sell its eye care business to Johnson & Johnson

for about $4.33 billion in cash to focus on cardiovascular

devices and diagnostics business.

Read more